At a glance
ClinicalIndex Comparison RecordN/ACompleted· 181 enrolled
Drug / intervention
Radiesse injectable implant (dermal filler) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds
In Brief
A clinical study evaluating Radiesse injectable implant (dermal filler) and Restylane injectable implant (dermal filler) for Correction of the Moderate to Severe Nasolabial Folds. Completed, enrolled 181 participants across 4 sites.
Detailed Summary
The objectives of this study are to evaluate the effectiveness and safety of Radiesse for the correction of nasolabial folds (NLFs).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
First PostedSep 2017
Primary CompletionJul 2018
Study CompletionNov 2018
TodayJul 2026
First PostedSep 13, 2017
Enrollment StartJul 27, 2017
Primary CompletionJul 17, 2018
Study CompletionNov 30, 2018
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 8.8 years ago
Interventions
Radiesse injectable implant (dermal filler)device
Subdermal injection.
Restylane injectable implant (dermal filler)device
Subdermal injection